Table 1.
NHS Trust affiliation, specialty and subspecialty of all contacted (n = 124) and confirmed (n = 29) mentors
| Contacted Mentorsa | Confirmed Mentorsa | |
|---|---|---|
| NHS Foundation Trust | ||
| Barts Health | 36 (29.0) | 12 (41.4) |
| University Hospitals Birmingham | 49 (39.5) | 13 (44.8) |
| King’s College Hospital | 39 (31.5) | 4 (13.8) |
| Specialty | ||
| Medical Oncology | 56 (45.5) | 11 (37.9) |
| Clinical/Radiation Oncology | 29 (23.6) | 8 (27.6) |
| Surgical Oncology | 31 (24.4) | 10 (34.5) |
| Other* | 7 (5.7) | – |
| Subspecialtyb | ||
| Bone cancer | 1 (0.8) | – |
| Brain cancer | 5 (4.0) | 2 (6.9) |
| Breast cancer | 40 (32.3) | 7 (24.1) |
| Colorectal cancer | 13 (10.5) | 6 (20.7) |
| Gastrointestinal cancer | 21 (16.9) | 4 (13.8) |
| Germ cell tumours | 3 (2.4) | – |
| Gynaecological cancer | 15 (12.1) | 3 (10.4) |
| Haematological cancer | 7 (5.7) | 1 (3.5) |
| Head and neck cancer | 8 (6.5) | – |
| Hepatobiliary cancer | 8 (6.5) | 1 (3.5) |
| Lung cancer | 26 (21.0) | 6 (20.7) |
| Lymphoma | 11 (8.9) | 3 (10.4) |
| Melanoma | 4 (3.2) | 2 (6.9) |
| Neuroendrocine cancer | 5 (4.0) | 2 (6.9) |
| Neurological cancer | 4 (3.2) | – |
| Paediatric cancer | 2 (1.6) | 1 (3.5) |
| Sarcoma | 9 (7.3) | 5 (17.2) |
| Skin cancer | 9 (7.3) | 3 (10.4) |
| Teenager and young adult cancer | 2 (1.6) | – |
| Urological cancer | 31 (25.0) | 8 (27.6) |
aData given as number of mentors (%)
bOne or more subspecialties per mentor
*Other specialties included cardiology (n = 1), haematology (n = 3), palliative medicine (n = 2) and pneumonology (n = 1) cancer specialists